Biblio

Export 794 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Humans  [Clear All Filters]
2016
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L., “miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
C. Stockburger, Miano, D., Baeumlisberger, M., Pallas, T., Arrey, T. N., Karas, M., Friedland, K., and Müller, W. E., “A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.”, J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G., “Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
M. Zhu, Huang, C., Ma, X., Wu, R., Zhu, W., Li, X., Liang, Z., Deng, F., Zhu, J., Xie, W., Yang, X., Jiang, Y., Wang, S., Wu, J., Geng, S., Xie, C., and Zhong, C., “Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1149-62, 2016.
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., “Molecular markers of amnestic mild cognitive impairment among Mexican Americans.”, J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
M. Chakrabarti, McDonald, A. J., J Reed, W., Moss, M. A., Das, B. C., and Ray, S. K., “Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., “Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.”, J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
A. Ezra, Rabinovich-Nikitin, I., Rabinovich-Toidman, P., and Solomon, B., “Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.”, J Alzheimers Dis, vol. 50, no. 1, pp. 175-88, 2016.
P. Eustache, Nemmi, F., Saint-Aubert, L., Pariente, J., and Péran, P., “Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1035-50, 2016.
K. J. Peck, Girard, T. A., Russo, F. A., and Fiocco, A. J., “Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.”, J Alzheimers Dis, vol. 51, no. 4, pp. 949-59, 2016.
M. Frenkel-Pinter, Tal, S., Scherzer-Attali, R., Abu-Hussien, M., Alyagor, I., Eisenbaum, T., Gazit, E., and Segal, D., “Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.”, J Alzheimers Dis, vol. 51, no. 1, pp. 165-78, 2016.
S. V. Ovsepian and O'Leary, V. B., “Neuronal activity and amyloid plaque pathology: an update.”, J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
R. Lizio, Del Percio, C., Marzano, N., Soricelli, A., Yener, G. G., Başar, E., Mundi, C., De Rosa, S., Triggiani, A. Ivano, Ferri, R., Arnaldi, D., Nobili, F. Mariano, Cordone, S., Lopez, S., Carducci, F., Santi, G., Gesualdo, L., Rossini, P. M., Cavedo, E., Mauri, M., Frisoni, G. B., and Babiloni, C., “Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.”, J Alzheimers Dis, vol. 49, no. 1, pp. 159-77, 2016.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
H. Leinonen, Lipponen, A., Gurevicius, K., and Tanila, H., “Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 51, no. 1, pp. 21-6, 2016.
M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., “Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
A. Savastano, Klafki, H., Haußmann, U., Oberstein, T. Jan, Muller, P., Wirths, O., Wiltfang, J., and Bayer, T. A., “N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.”, J Alzheimers Dis, vol. 49, no. 1, pp. 101-10, 2016.
C. Sanders, Behrens, S., Schwartz, S., Wengreen, H., Corcoran, C. D., Lyketsos, C. G., and Tschanz, J. A. T., “Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.”, J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.
G. Tumminelli, Di Donato, I., Guida, V., Rufa, A., De Luca, A., and Federico, A., “Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene.”, J Alzheimers Dis, vol. 49, no. 1, pp. 27-30, 2016.
D. A. Nation, Ho, J., and Yew, B., “Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.”, J Alzheimers Dis, vol. 50, no. 3, pp. 779-89, 2016.
A. Oulhaj, Jernerén, F., Refsum, H., A Smith, D., and de Jager, C. A., “Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.
J. M. Robillard, “The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 11-3, 2016.
C. Lange, Suppa, P., Frings, L., Brenner, W., Spies, L., and Buchert, R., “Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.”, J Alzheimers Dis, vol. 49, no. 4, pp. 945-59, 2016.
S. Lim, Choi, J. Gyu, Moon, M., Kim, H. Geun, Lee, W., Bak, H. - R., Sung, H., Park, C. Hye, Kim, S. Yeou, and Oh, M. Sook, “An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.”, J Alzheimers Dis, vol. 50, no. 1, pp. 189-200, 2016.

Pages